Get Live Data

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. probiotix health Share Price
  4. probiotix health Share Regulatory News
  5. Total Voting Rights

Pin to quick picksprobiotix health Regulatory News (PBX.PL)

probiotix health Information

Share Price Information for probiotix health (PBX.PL)

Share Price is delayed by 15 minutes
Get Live Data
7.75    0.00 (0.00%)
Bid:
7.50
Ask:
8.00
Spread: 0.50 (6.667%)
Market Cap: £12.26m
PBX.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday probiotix health Share Chart

Total Voting Rights

30 Sep 2024 14:03

RNS Number : 2865G
Probiotix Health PLC
30 September 2024
 

30 September 2024

ProBiotix Health plc

("ProBiotix" or the "Company" or, together with its subsidiary, the "Group")

 

Total Voting Rights

 

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces that the Company has 158,166,666 ordinary shares of 0.05p each in issue ("Ordinary Shares"), each share carrying the right to one vote.

 

This figure of 158,166,666 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

 

ProBiotix Health plc

https://probiotixhealth-ir.com/

Steen Andersen, Chief Executive Officer

 

Peterhouse Capital Limited

Aquis Corporate Adviser And Broker

Tel: 020 7220 9793

Mark Anwyl

 

Walbrook PR Ltd

Anna Dunphy

 

probiotix@walbrookpr.com

Mob: 07876 741 001

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAANEDSXLEFA
12
Date   Source Headline
23rd Jun 20261:00 pmRNSResult of AGM
1st Jun 20267:00 amRNSNew Partnership Agreement in Slovakia
29th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSNew Strategic Alliance in Spain and Portugal
30th Mar 20267:00 amRNSFinal Results and Investor Presentation
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
17th Feb 20267:00 amRNSPDMR Shareholding
16th Feb 202612:30 pmRNSStatement re Share Price Movement
5th Feb 20265:00 pmRNSHolding(s) in Company
4th Feb 20267:00 amRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
3rd Nov 20257:00 amRNSMove from Access to Apex Segment of Aquis
23rd Oct 20257:00 amRNSAppointment of Aquis Corporate Adviser
20th Oct 20257:00 amRNSNew Commercial Partnership in Australia
14th Oct 20252:00 pmRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSNew Commercial Partnership in Sweden
13th Oct 20257:00 amRNSQ3 2025 Trading Update and Grant of Options
8th Sep 20257:00 amRNSUnaudited Interim Results to 30 June 2025
15th Jul 20257:00 amRNSTrading Update and Notice of Results
27th Jun 202512:35 pmRNSResult of AGM and Notice of Trading Update
9th Jun 20254:15 pmRNSPDMR Shareholding
5th Jun 20255:30 pmRNSNotice of Annual General Meeting - Clarification
30th May 20257:01 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSNotice of AGM
29th May 20257:00 amRNSFinal Results
7th May 20257:00 amRNSNotice of Results and Investor Presentation
28th Mar 20257:00 amRNSNew Partnership Agreement in South Korea
20th Feb 20257:01 amRNSGrant of Options
20th Feb 20257:01 amRNSGrant of Options
20th Feb 20257:00 amRNSMajor new Supply Agreement in the Far East
20th Feb 20257:00 amRNSMajor new Supply Agreement in the Far East
23rd Jan 20257:00 amRNSTrading Update
5th Nov 20243:33 pmRNSDirector/PDMR Shareholding
1st Nov 202410:56 amRNSResult of Requisitioned General Meeting
30th Oct 20247:00 amRNSRequisition update
18th Oct 20247:00 amRNSResponse to Publication of Circular by ProBiotix
15th Oct 20247:00 amRNSPublication of Circular and Notice of GM
10th Oct 20247:00 amRNSNew Commercial Partnership in Mexico
8th Oct 20247:00 amRNSQ3 2024 Trading Update
7th Oct 20247:00 amRNSAppointment of Non-Executive Director
3rd Oct 20247:00 amRNSNew Commercial Partnership in Ukraine
30th Sep 20242:03 pmRNSTotal Voting Rights
27th Sep 202411:23 amRNSHolding(s) in Company
25th Sep 20247:05 amRNSResponse to General Meeting Requisition
25th Sep 20247:00 amRNSGeneral Meeting Requisition Notice
16th Sep 20247:00 amRNSNew Commercial Partnership in Greece
6th Sep 20242:08 pmRNSResponse to OptiBiotix Health plc announcement
4th Sep 20247:00 amRNSShare Subscription and Proposed Board Appointment
30th Aug 20247:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IUKP.MI
Ishares Uk Property Ucits Etf Gbp Dist
MI
0.468%
SP20
S&p 500 Usd Acc
LSE
0.27%
JMBS.US
Janus Henderson Mortgage-backed Securities Etf
CBOE
0.00%
HSWD.PA
Hsbc Developed World Screened Equity Ucits Etf
PA
0.00%
SD42
Corp Andina 25
LSE
0.00%
Trending
EZJ
easyJet
LSE
0.04%
GGP
Greatland Resources
LSE
0.92%
HEX
Helix Exploration
LSE
-7.88%
EUA
Eurasia Mining
LSE
0.00%
TEXF.BR
Texaf
BR
-0.98%